Testing a new knee replacement for first-time and repeat knee surgery
Tests the FHK®-CK knee prosthesis in adults needing knee replacement or revision.
Key facts
- Who runs it
- FH ORTHO
- Where
- France7 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Performance and Safety Evaluation of the FHK®-CK Knee Prosthesis
- Status
- Recruiting
- People taking part
- 92 people, planned
- Started
- 1 Feb 2024
- Expected to end
- Feb 2028
- Type of study
- Interventional
- Treatments tested
- Total Knee arthroplasty
- Record updated
- 19 June 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Patient requiring knee arthroplasty for primary or secondary gonarthrosis:; For primary intention arthroplasty: Patient with either; major axial deviation,; major peripheral failure or; bone defect; For prosthesis revision surgery: Patient who have had a failed 1st implantation, with or without bone defects
- Patient able to understand and answer the questionnaires provided by the protocol
- Subject affiliated to a health insurance system or is a beneficiary
- Signed informed consent form (ICF) for participation to the research
Who cannot take part
- Patient with a dependency (drug, alcohol,…) that could affect his/ her ability to comply with the protocol, at the investigator's discretion
- Patient with an ongoing acute infection, outside knee to be operated
- Patient with a mental or neuromuscular disorder that would create an unacceptable risk of prosthetic instability, prosthetic fixation failure or post-operative complications
- Patient with a known allergy to any of the components of the FHK®-CK implants (Nickel, Cobalt, Chromium)
- Vulnerable subjects :; Pregnant, parturient, or breastfeeding women,; Subject deprived of liberty, hospitalized without consent or admitted to a health or social establishment for purposes other than that of research,; Minor,; Adult under protective supervision (tutorship, curatorship),; Subject not able to understand the subject information leaflet (e.g. for linguistic or psychiatric reasons) and/or to give informed consent
- Patient requiring knee reconstruction
- Patient with any medically significant findings or significant history that may impact the safety, interpretation of results, and/ or participation of the subject in the clinical trial, as determined by the investigator
- Patient with an existing knee or hip prosthesis (outside knee to be operated) that may impact the evaluation of the FHK®-CK prosthesis
- Patient concurrently participating in another clinical trial or who has recently participated in another clinical trial for which the exclusion period has not been completed
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The life expectancy worldwide is increasing and leading to an increase of knee arthroplasty. Also, as millions of people around the world are currently living with a Total Knee Arthroplasty (TKA), the need for revision surgery represents a large public health burden. In this context, FH ORTHO company develops FHK®-CK (prosthesis + ancillary equipment) which is a knee prosthesis for complex first intention and revision knee arthroplasty. This new medical device complements the FHK® standard first-line range (CE marked).
Read full original descriptionShow less
The FHK®-CK ancillary equipment were designed by expert knee surgeons and is simple, reliable and reproducible. It allows for maximum versatility while remaining compact.
By completing the FHK® range of first intention prostheses, the FHK®-CK allows the surgeon to be on the same level as the competitors by having a first intention and semi-constrained prosthesis. This prosthetic arsenal allows the surgeon to opt for the best solution for his patient so that he can regain mobility and a satisfactory quality of life. Also, in case of failure of the FHK® first-line prosthesis, it will provide the surgeon and the patient with a simple alternative to prosthesis replacement. As it has been developed in line with the first intention, inter-compatibility between the two systems is possible, which simplifies the surgical procedure and reduces the risks for the patient.
The group in the trial
- Knee replacementTreatment being tested
Implantation of FHK-CK prosthesis either for a complex primary arthroplasty or for revision intend
Treatment: Total Knee arthroplasty
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Performance and Safety Evaluation of the FHK®-CK Knee Prosthesis Indicated for the Treatment of Primary and Secondary First Line Gonarthrosis and Revision Arthroplasty - 2 Years Follow-up - A Pilot Study
- Plain-language title
- Testing a new knee replacement for first-time and repeat knee surgeryGenerated from the registry record. The registry title is the official one.
- Record updated
- 19 June 2025